These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34921512)

  • 1. Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120.
    Moseri A; Akabayov SR; Cohen LS; Naider F; Anglister J
    FEBS J; 2022 Jun; 289(11):3132-3147. PubMed ID: 34921512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.
    Schnur E; Noah E; Ayzenshtat I; Sargsyan H; Inui T; Ding FX; Arshava B; Sagi Y; Kessler N; Levy R; Scherf T; Naider F; Anglister J
    J Mol Biol; 2011 Jul; 410(5):778-97. PubMed ID: 21763489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining specific residue-to-residue interactions between the gp120 bridging sheet and the N-terminal segment of CCR5: applications of transferred NOE NMR.
    Srivastava G; Moseri A; Kessler N; Arshava B; Naider F; Anglister J
    FEBS J; 2018 Nov; 285(22):4296-4310. PubMed ID: 30288935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of intermolecular transferred NOEs in large protein complexes using asymmetric deuteration: HIV-1 gp120 in complex with a CCR5 peptide.
    Srivastava G; Moseri A; Kessler N; Akabayov SR; Arshava B; Naider F; Anglister J
    FEBS J; 2016 Nov; 283(22):4084-4096. PubMed ID: 27701820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry.
    Lam SN; Acharya P; Wyatt R; Kwong PD; Bewley CA
    Bioorg Med Chem; 2008 Dec; 16(23):10113-20. PubMed ID: 18952441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokines CCL5 and CXCL12 exhibit high-affinity binding to N-terminal peptides of the non-cognate receptors CXCR4 and CCR5, respectively.
    Kessler N; Akabayov SR; Cohen LS; Scherf T; Naider F; Anglister J
    FEBS J; 2024 Feb; 291(3):458-476. PubMed ID: 37997026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.
    Abayev M; Moseri A; Tchaicheeyan O; Kessler N; Arshava B; Naider F; Scherf T; Anglister J
    FEBS J; 2015 May; 282(10):1906-1921. PubMed ID: 25703038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of intermolecular transferred-NOE interactions in small and medium size protein complexes: RANTES complexed with a CCR5 N-terminal peptide.
    Abayev M; Srivastava G; Arshava B; Naider F; Anglister J
    FEBS J; 2017 Feb; 284(4):586-601. PubMed ID: 28052516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.
    Brower ET; Schön A; Klein JC; Freire E
    Biochemistry; 2009 Feb; 48(4):779-85. PubMed ID: 19170639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
    Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
    J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
    Cormier EG; Tran DN; Yukhayeva L; Olson WC; Dragic T
    J Virol; 2001 Jun; 75(12):5541-9. PubMed ID: 11356961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.
    Farzan M; Vasilieva N; Schnitzler CE; Chung S; Robinson J; Gerard NP; Gerard C; Choe H; Sodroski J
    J Biol Chem; 2000 Oct; 275(43):33516-21. PubMed ID: 10938094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
    Mechulam A; Cerutti M; Pugnière M; Missé D; Gajardo J; Roquet F; Robinson J; Veas F
    J Mol Med (Berl); 2005 Jul; 83(7):542-52. PubMed ID: 15905975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
    Liu S; Fan S; Sun Z
    J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.
    Choe H; Li W; Wright PL; Vasilieva N; Venturi M; Huang CC; Grundner C; Dorfman T; Zwick MB; Wang L; Rosenberg ES; Kwong PD; Burton DR; Robinson JE; Sodroski JG; Farzan M
    Cell; 2003 Jul; 114(2):161-70. PubMed ID: 12887918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
    Cormier EG; Dragic T
    J Virol; 2002 Sep; 76(17):8953-7. PubMed ID: 12163614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
    Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
    Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection.
    Dorfman T; Moore MJ; Guth AC; Choe H; Farzan M
    J Biol Chem; 2006 Sep; 281(39):28529-35. PubMed ID: 16849323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.
    Quinlan BD; Joshi VR; Gardner MR; Ebrahimi KH; Farzan M
    J Virol; 2014 Mar; 88(6):3353-8. PubMed ID: 24390333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.